RCAR (RenovaCare) Common Stock: $0.00 Mil (As of Sep. 2022)


What is RenovaCare Common Stock?

RenovaCare RCAR -99.00% Common Stock is $0.00 Mil as of Sep. 2022.

RenovaCare's quarterly common stock stayed the same from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) and stayed the same from Jun. 2022 ($0.00 Mil) to Sep. 2022 ($0.00 Mil).

RenovaCare's annual common stock stayed the same from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) and stayed the same from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil).

RenovaCare Common Stock Historical Data

* Premium members only.

The historical data trend for RenovaCare's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RenovaCare Common Stock Chart

RenovaCare Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RenovaCare Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RenovaCare Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
RenovaCare (RCAR) has a Common Stock of $0.00 Mil as of Sep. 2022. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RenovaCare and its competitors.
Is RenovaCare's Common Stock too high?
RenovaCare's current Common Stock is $0.00 Mil.
How does RenovaCare's Common Stock compare to ONCSQ and STAB?
RenovaCare's Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RenovaCare and its competitors. RenovaCare's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RenovaCare stock overvalued right now?
RenovaCare (RCAR) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For RenovaCare (RCAR), the current Common Stock is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RenovaCare Business Description

Address 9375 East Shea Boulvard, Suite 107-A, Scottsdale, AZ, USA, 85260
RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.